Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 284

1.

The Challenge of Rare Diseases.

Stoller JK.

Chest. 2018 Jan 8. pii: S0012-3692(18)30064-3. doi: 10.1016/j.chest.2017.12.018. [Epub ahead of print]

PMID:
29325986
2.
3.

The Long-Term Oxygen Treatment Trial for Chronic Obstructive Pulmonary Disease: Rationale, Design, and Lessons Learned.

Yusen RD, Criner GJ, Sternberg AL, Au DH, Fuhlbrigge AL, Albert RK, Casaburi R, Stoller JK, Harrington KF, Cooper JAD Jr, Diaz P, Gay S, Kanner R, MacIntyre N, Martinez FJ, Piantadosi S, Sciurba F, Shade D, Stibolt T, Tonascia J, Wise R, Bailey WC; LOTT Research Group * ; LOTT Research Group.

Ann Am Thorac Soc. 2018 Jan;15(1):89-101. doi: 10.1513/AnnalsATS.201705-374SD.

PMID:
29087741
4.

Respiratory Therapist-Managed Arterial Catheter Insertion and Maintenance Program: Experience in a Non-Teaching Community Hospital.

Pack S, Hahn PY, Stoller JK, Mummadi SR.

Respir Care. 2017 Dec;62(12):1520-1524. doi: 10.4187/respcare.05486. Epub 2017 Oct 3.

PMID:
28974644
5.

The architecture of clinical research (From the "Biostatistics and Epidemiology Lecture Series, Part 1").

Stoller JK.

Cleve Clin J Med. 2017 Sep;84(9 Suppl 2):e2-e9. doi: 10.3949/ccjm.84.s2.02. No abstract available.

6.

Serum Proteins Associated with Emphysema Progression in Severe Alpha-1 Antitrypsin Deficiency.

Beiko T, Janech MG, Alekseyenko AV, Atkinson C, Coxson HO, Barth JL, Stephenson SE, Wilson CL, Schnapp LM, Barker A, Brantly M, Sandhaus RA, Silverman EK, Stoller JK, Trapnell B, Charlie S.

Chronic Obstr Pulm Dis. 2017 Jul 15;4(3):204-216. doi: 10.15326/jcopdf.4.3.2016.0180.

7.

Assessing the kinetics of microbubble appearance in cirrhotic patients using transthoracic saline contrast-enhanced echocardiography.

Tonelli AR, Naal T, Dakkak W, Park MM, Dweik RA, Stoller JK.

Echocardiography. 2017 Oct;34(10):1439-1446. doi: 10.1111/echo.13662. Epub 2017 Aug 25.

PMID:
28840954
8.

The Clinician as Leader: Why, How, and When.

Stoller JK.

Ann Am Thorac Soc. 2017 Nov;14(11):1622-1626. doi: 10.1513/AnnalsATS.201706-494PS.

PMID:
28771027
9.

Impact of a Post-Discharge Integrated Disease Management Program on COPD Hospital Readmissions.

Russo AN, Sathiyamoorthy G, Lau C, Saygin D, Han X, Wang XF, Rice R, Aboussouan LS, Stoller JK, Hatipoğlu U.

Respir Care. 2017 Nov;62(11):1396-1402. doi: 10.4187/respcare.05547. Epub 2017 Aug 1.

PMID:
28765496
10.

Alpha-1 Antitrypsin Deficiency.

Stoller JK, Lacbawan FL, Aboussouan LS.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2018.
2006 Oct 27 [updated 2017 Jan 19].

11.

A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation.

Long-Term Oxygen Treatment Trial Research Group, Albert RK, Au DH, Blackford AL, Casaburi R, Cooper JA Jr, Criner GJ, Diaz P, Fuhlbrigge AL, Gay SE, Kanner RE, MacIntyre N, Martinez FJ, Panos RJ, Piantadosi S, Sciurba F, Shade D, Stibolt T, Stoller JK, Wise R, Yusen RD, Tonascia J, Sternberg AL, Bailey W.

N Engl J Med. 2016 Oct 27;375(17):1617-1627.

12.

Developing leadership competencies among medical trainees: five-year experience at the Cleveland Clinic with a chief residents' training course.

Farver CF, Smalling S, Stoller JK.

Australas Psychiatry. 2016 Oct;24(5):499-505. doi: 10.1177/1039856216632396.

PMID:
27683857
13.

Focal lung infiltrate complicating PD-1 inhibitor use: A new pattern of drug-associated lung toxicity?

Sehgal S, Velcheti V, Mukhopadhyay S, Stoller JK.

Respir Med Case Rep. 2016 Sep 8;19:118-20. doi: 10.1016/j.rmcr.2016.09.001. eCollection 2016.

14.

Detecting Alpha-1 Antitrypsin Deficiency.

Stoller JK.

Ann Am Thorac Soc. 2016 Aug;13 Suppl 4:S317-25. doi: 10.1513/AnnalsATS.201506-349KV. Review.

PMID:
27564667
15.

α1-Antitrypsin Deficiency.

Hatipoğlu U, Stoller JK.

Clin Chest Med. 2016 Sep;37(3):487-504. doi: 10.1016/j.ccm.2016.04.011. Epub 2016 Jun 25. Review.

PMID:
27514595
16.

α1-Antitrypsin deficiency.

Greene CM, Marciniak SJ, Teckman J, Ferrarotti I, Brantly ML, Lomas DA, Stoller JK, McElvaney NG.

Nat Rev Dis Primers. 2016 Jul 28;2:16051. doi: 10.1038/nrdp.2016.51. Review.

PMID:
27465791
17.

Alpha-1 antitrypsin deficiency: An underrecognized, treatable cause of COPD.

Stoller JK.

Cleve Clin J Med. 2016 Jul;83(7):507-14. doi: 10.3949/ccjm.83a.16031. Review.

18.

The Diagnosis and Management of Alpha-1 Antitrypsin Deficiency in the Adult.

Sandhaus RA, Turino G, Brantly ML, Campos M, Cross CE, Goodman K, Hogarth DK, Knight SL, Stocks JM, Stoller JK, Strange C, Teckman J.

Chronic Obstr Pulm Dis. 2016 Jun 6;3(3):668-682. doi: 10.15326/jcopdf.3.3.2015.0182. Review.

19.

Physician leadership development at Cleveland Clinic: a brief review.

Christensen T, Stoller JK.

Australas Psychiatry. 2016 Jun;24(3):235-9. doi: 10.1177/1039856216635907. Epub 2016 Feb 25.

PMID:
26917854
20.

Characteristics of Alpha-1 Antitrypsin-Deficient Individuals in the Long-term Oxygen Treatment Trial and Comparison with Other Subjects with Chronic Obstructive Pulmonary Disease.

Stoller JK, Aboussouan LS, Kanner RE, Wilson LA, Diaz P, Wise R; LOTT Research Group.

Ann Am Thorac Soc. 2015 Dec;12(12):1796-804. doi: 10.1513/AnnalsATS.201506-389OC.

21.

The Natural History of Lung Function in Severe Deficiency of Alpha-1 Antitrypsin Following Orthotopic Liver Transplantation: A Case Report.

Tejwani V, Wang XF, Stoller JK.

Chronic Obstr Pulm Dis. 2015 Sep 10;2(4):290-295. doi: 10.15326/jcopdf.2.4.2015.0141.

22.

Respiratory Therapist Job Perceptions: The Impact of Protocol Use.

Metcalf AY, Stoller JK, Habermann M, Fry TD.

Respir Care. 2015 Nov;60(11):1556-9. doi: 10.4187/respcare.04156. Epub 2015 Aug 25.

23.

Granulomatosis with polyangiitis and associated pulmonary emphysema: Breathtaking vasculitis.

Gadre SK, Stoller JK, Mehta AC.

Lung India. 2015 Jul-Aug;32(4):367-9. doi: 10.4103/0970-2113.159576.

24.

Alpha-1 antitrypsin deficiency and the risk of hepatocellular carcinoma in end-stage liver disease.

Antoury C, Lopez R, Zein N, Stoller JK, Alkhouri N.

World J Hepatol. 2015 Jun 8;7(10):1427-32. doi: 10.4254/wjh.v7.i10.1427.

25.

An official American Thoracic Society/European Respiratory Society statement: research questions in COPD.

Celli BR, Decramer M, Wedzicha JA, Wilson KC, Agustí AA, Criner GJ, MacNee W, Make BJ, Rennard SI, Stockley RA, Vogelmeier C, Anzueto A, Au DH, Barnes PJ, Burgel PR, Calverley PM, Casanova C, Clini EM, Cooper CB, Coxson HO, Dusser DJ, Fabbri LM, Fahy B, Ferguson GT, Fisher A, Fletcher MJ, Hayot M, Hurst JR, Jones PW, Mahler DA, Maltais F, Mannino DM, Martinez FJ, Miravitlles M, Meek PM, Papi A, Rabe KF, Roche N, Sciurba FC, Sethi S, Siafakas N, Sin DD, Soriano JB, Stoller JK, Tashkin DP, Troosters T, Verleden GM, Verschakelen J, Vestbo J, Walsh JW, Washko GR, Wise RA, Wouters EF, ZuWallack RL; ATS/ERS Task Force for COPD Research.

Eur Respir Rev. 2015 Jun;24(136):159-72. doi: 10.1183/16000617.00000315. Review.

26.

Response.

Stoller JK, Banga A, Mehta AC.

Chest. 2015 May;147(5):e190-e191. doi: 10.1378/chest.15-0126. No abstract available.

PMID:
25940265
27.

Characteristics of Chronic Obstructive Pulmonary Disease (COPD) Patients Reporting Alpha-1 Antitrypsin Deficiency in the WebMD Lung Health Check Database.

McGrady T, Mannino DM, Malanga E, Thomashow BM, Walsh J, Sandhaus RA, Stoller JK.

Chronic Obstr Pulm Dis. 2015 Apr 15;2(2):141-151. doi: 10.15326/jcopdf.2.2.2015.0160.

28.

An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease.

Celli BR, Decramer M, Wedzicha JA, Wilson KC, Agustí A, Criner GJ, MacNee W, Make BJ, Rennard SI, Stockley RA, Vogelmeier C, Anzueto A, Au DH, Barnes PJ, Burgel PR, Calverley PM, Casanova C, Clini EM, Cooper CB, Coxson HO, Dusser DJ, Fabbri LM, Fahy B, Ferguson GT, Fisher A, Fletcher MJ, Hayot M, Hurst JR, Jones PW, Mahler DA, Maltais F, Mannino DM, Martinez FJ, Miravitlles M, Meek PM, Papi A, Rabe KF, Roche N, Sciurba FC, Sethi S, Siafakas N, Sin DD, Soriano JB, Stoller JK, Tashkin DP, Troosters T, Verleden GM, Verschakelen J, Vestbo J, Walsh JW, Washko GR, Wise RA, Wouters EF, ZuWallack RL; ATS/ERS Task Force for COPD Research.

Am J Respir Crit Care Med. 2015 Apr 1;191(7):e4-e27. doi: 10.1164/rccm.201501-0044ST.

PMID:
25830527
29.

An official American Thoracic Society/European Respiratory Society statement: research questions in COPD.

Celli BR, Decramer M, Wedzicha JA, Wilson KC, Agustí A, Criner GJ, MacNee W, Make BJ, Rennard SI, Stockley RA, Vogelmeier C, Anzueto A, Au DH, Barnes PJ, Burgel PR, Calverley PM, Casanova C, Clini EM, Cooper CB, Coxson HO, Dusser DJ, Fabbri LM, Fahy B, Ferguson GT, Fisher A, Fletcher MJ, Hayot M, Hurst JR, Jones PW, Mahler DA, Maltais F, Mannino DM, Martinez FJ, Miravitlles M, Meek PM, Papi A, Rabe KF, Roche N, Sciurba FC, Sethi S, Siafakas N, Sin DD, Soriano JB, Stoller JK, Tashkin DP, Troosters T, Verleden GM, Verschakelen J, Vestbo J, Walsh JW, Washko GR, Wise RA, Wouters EF, ZuWallack RL; ATS/ERS Task Force for COPD Research.

Eur Respir J. 2015 Apr;45(4):879-905. doi: 10.1183/09031936.00009015. Review.

30.

Patterns and factors associated with respiratory care protocol use.

Metcalf AY, Stoller JK, Fry TD, Habermann M.

Respir Care. 2015 May;60(5):636-43. doi: 10.4187/respcare.03699. Epub 2015 Jan 27.

31.

Rebuttal from Dr Mehta et al.

Mehta AC, Banga A, Stoller JK.

Chest. 2015 Jan;147(1):17-18. doi: 10.1378/chest.14-2236. No abstract available.

PMID:
25560857
32.

Counterpoint: Are the CHEST guidelines global in coverage? No.

Mehta AC, Banga A, Stoller JK.

Chest. 2015 Jan;147(1):13-15. doi: 10.1378/chest.14-2235. Review. No abstract available.

PMID:
25560855
33.

A Case in Point: When Extended Genotyping of α-1 Antitrypsin (SERPINA1) is Indicated.

Ricci KS, Kwong S, Stoller JK, Lacbawan F.

Appl Immunohistochem Mol Morphol. 2015 Nov-Dec;23(10):744. doi: 10.1097/PAI.0000000000000101. No abstract available.

PMID:
25390356
34.

The Cleveland Clinic: a distinctive model of American medicine.

Stoller JK.

Ann Transl Med. 2014 Apr;2(4):33. doi: 10.3978/j.issn.2305-5839.2013.12.02.

35.

Developing a leadership pipeline: the Cleveland Clinic experience.

Hess CA, Barss C, Stoller JK.

Perspect Med Educ. 2014 Nov;3(5):383-90. doi: 10.1007/s40037-014-0135-y.

36.

The natural history of lung function after lung transplantation for α(1)-antitrypsin deficiency.

Banga A, Gildea T, Rajeswaran J, Rokadia H, Blackstone EH, Stoller JK.

Am J Respir Crit Care Med. 2014 Aug 1;190(3):274-81. doi: 10.1164/rccm.201401-0031OC.

PMID:
25003824
37.

Help wanted: developing clinician leaders.

Stoller JK.

Perspect Med Educ. 2014 Jun;3(3):233-7. doi: 10.1007/s40037-014-0119-y.

38.

A systematic review of physician leadership and emotional intelligence.

Mintz LJ, Stoller JK.

J Grad Med Educ. 2014 Mar;6(1):21-31. doi: 10.4300/JGME-D-13-00012.1.

39.

Circulating polymers in α1-antitrypsin deficiency.

Tan L, Dickens JA, Demeo DL, Miranda E, Perez J, Rashid ST, Day J, Ordoñez A, Marciniak SJ, Haq I, Barker AF, Campbell EJ, Eden E, McElvaney NG, Rennard SI, Sandhaus RA, Stocks JM, Stoller JK, Strange C, Turino G, Rouhani FN, Brantly M, Lomas DA.

Eur Respir J. 2014 May;43(5):1501-4. doi: 10.1183/09031936.00111213. Epub 2014 Mar 6. No abstract available.

40.

First time rounding experiences for nonclinicians: the Cleveland Clinic experience.

Greenwald LR, Nowacki AS, Stoller JK.

Am J Med Qual. 2015 Mar-Apr;30(2):167-71. doi: 10.1177/1062860614521657. Epub 2014 Feb 11.

PMID:
24519444
41.

Biphasic capnogram in a single-lung transplant recipient: a case report.

Rai HS, Boehm JK, Stoller JK.

Respir Care. 2014 Aug;59(8):E108-9.

42.

Clinical characteristics and prediction of pulmonary hypertension in severe emphysema.

Minai OA, Fessler H, Stoller JK, Criner GJ, Scharf SM, Meli Y, Nutter B, DeCamp MM; NETT Research Group.

Respir Med. 2014 Mar;108(3):482-90. doi: 10.1016/j.rmed.2013.11.006. Epub 2013 Nov 19.

43.

Detection of alpha-1 antitrypsin deficiency by respiratory therapists: experience with an educational program.

Stoller JK, Strange C, Schwarz L, Kallstrom TJ, Chatburn RL.

Respir Care. 2014 May;59(5):667-72. doi: 10.4187/respcare.02817. Epub 2013 Oct 8.

44.

The scientific basis for protocol-directed respiratory care.

Modrykamien AM, Stoller JK.

Respir Care. 2013 Oct;58(10):1662-8. doi: 10.4187/respcare.02195. Review.

45.

Just imagine: new paradigms for medical education.

Mehta NB, Hull AL, Young JB, Stoller JK.

Acad Med. 2013 Oct;88(10):1418-23. doi: 10.1097/ACM.0b013e3182a36a07.

PMID:
23969368
46.

Elastin degradation products as biomarkers in alpha-1 antitrypsin deficiency: lastin' impact?

Stoller JK.

COPD. 2013 Aug;10(4):403-4. doi: 10.3109/15412555.2013.811987. No abstract available.

PMID:
23875739
47.

Radio-frequency tracking of respiratory equipment: rationale and early experience at the Cleveland Clinic.

Stoller JK, Roberts V, Matt D, Chom L, Sasidhar M, Chatburn RL.

Respir Care. 2013 Dec;58(12):2069-75. doi: 10.4187/respcare.02545. Epub 2013 Jul 2.

48.

Electronic siloing: an unintended consequence of the electronic health record.

Stoller JK.

Cleve Clin J Med. 2013 Jul;80(7):406-9. doi: 10.3949/ccjm.80a.12172. No abstract available.

PMID:
23821682
49.

Communicating with graduate medical trainees: the Cleveland Clinic experience.

Greenwald LR, Stoller JK.

Perspect Med Educ. 2013 Jun;2(3):142-55. doi: 10.1007/s40037-013-0062-3.

50.

The challenge of detecting alpha-1 antitrypsin deficiency.

Stoller JK, Brantly M.

COPD. 2013 Mar;10 Suppl 1:26-34. doi: 10.3109/15412555.2013.763782. Review.

PMID:
23527684

Supplemental Content

Loading ...
Support Center